Answers are grounded in this paper and cite their sources.
Pseudomonas aeruginosa remains challenging to control because of intrinsic antimicrobial resistance and biofilm-associated tolerance, highlighting the need to explore alternative therapeutic strategies. This study investigated the in vitro effects of a pharmaceutical methotrexate (MTX) formulation on P. aeruginosa PAO1, its interaction with gentamicin (GEN), and the potential relevance of selected folate-pathway proteins. Planktonic growth inhibition, growth kinetics, developing and preformed biofilm biomass, and biofilm-associated membrane integrity were evaluated. MTX-GEN interactions were evaluated by checkerboard analysis, while comparative molecular docking of MTX, fluorofolin, and trimethoprim against FolA, FolC, FolD, and ThyA was complemented by STRING/KEGG network analysis. Exposure to the MTX formulation produced concentration-dependent growth suppression, reaching the predefined GI80 at 75 mg/mL (165.04 mM), corresponding to 82.83% growth inhibition. Lower concentrations altered attached biofilm biomass and membrane-integrity profiles. Global MTX-GEN interaction scores fell within the additive/indifferent range, while selected combinations showed sustained growth suppression and biofilm-associated responses. Exploratory molecular docking predicted potential MTX binding configurations within the four modeled folate-pathway proteins, while functional-network analysis highlighted functional associations involving folate-dependent one-carbon metabolism. Together, these findings provide an integrated experimental and computational characterization of PAO1 responses to pharmaceutical MTX formulation exposure and identify folate-associated metabolic processes as a focused direction for further mechanistic investigation.
No takes yet. Share an insight, caveat, or question.
Alhumaidan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: